| Seelos Therapeutics is a biopharmaceutical company focused on the development of product candidates in the areas of urology and rheumatology. Co. has two product candidates : Vitaros, a topically-applied cream formulation of alprostadil for the treatment of erectile dysfunction, which Co. in-licensed from Warner Chilcott Company, Inc.; and RayVa, a topically-applied cream formulation of alprostadil designed to dilate blood vessels for the treatment of Raynaud's Phenomenon, secondary to scleroderma, for which it owns worldwide rights. We show 10 historical shares outstanding datapoints in our APRI shares outstanding history coverage, used to compute APRI market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing APRI market cap history over the course of time is important for investors
interested in comparing APRI's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of APRI versus a peer is one thing; comparing
APRI market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like APRI can fluctuate over the course of history.
With this page we aim to empower investors researching APRI by allowing them to research the APRI market cap history.